Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Neurotensin receptor 2 (NTS2), also known as NTR2, is a G protein-coupled receptor (GPCR) that primarily binds the neuropeptide neurotensin. It is involved in modulating several physiological processes, especially within the central nervous system, including dopamine signaling, pain modulation, and thermal regulation. Its unique pharmacology, particularly its high sensitivity to levocabastine and the development of selective synthetic ligands, makes it a promising target for non-opioid analgesics and potential treatments for psychiatric or neurological disorders.
Activation of phosphatidylinositol-calcium second messenger system; competitive binding with neurotensin at the receptor site.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Neurotensin Receptor 2 (NTS2).